MYC and cancer: Previously, we reported in Myc oncogene-driven cancer, loss of one allele of Arf rescued the delay in tumorigenesis caused by Mdm2 heterozygosity, demonstrating Arf levels regulate Mdm2 during oncogene-induced tumorigenesis [15].